These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of thrombolytic therapy in acute myocardial infarction. Bradbury M; Cruickshank JP Br J Nurs; 1993 Jun 24-Jul 7; 2(12):619-24. PubMed ID: 8348005 [TBL] [Abstract][Full Text] [Related]
3. The number needed to harm: is it too optimistic? Mancini GB; Schulzer M Can J Cardiol; 2004 Nov; 20(13):1375; author reply 1376. PubMed ID: 15612137 [No Abstract] [Full Text] [Related]
4. Acute coronary syndromes: new developments in pharmacological treatment strategies. Gylys K; Gold M Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169 [No Abstract] [Full Text] [Related]
5. Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must? Danchin N Eur Heart J; 2005 Mar; 26(6):529-31. PubMed ID: 15713697 [No Abstract] [Full Text] [Related]
7. Thrombolysis for acute myocardial infarction: is proof of a reduction in mortality critical to drug selection? Green JA Clin Pharm; 1988 Jun; 7(6):473-7. PubMed ID: 3042271 [No Abstract] [Full Text] [Related]
8. Which patients with suspected myocardial ischemia and left bundle-branch block should receive thrombolytic agents? Gallagher EJ Ann Emerg Med; 2001 May; 37(5):439-44. PubMed ID: 11326178 [No Abstract] [Full Text] [Related]
9. What an interventional cardiologist should know about the pharmacological treatment of acute myocardial infarction. Verheugt FW Semin Interv Cardiol; 1999 Mar; 4(1):17-20. PubMed ID: 10406064 [TBL] [Abstract][Full Text] [Related]
10. [European Society of Cardiology guidelines on ST-elevation myocardial infarction: what is new?]. De Servi S; D'Urbano M G Ital Cardiol (Rome); 2009 Jul; 10(7):490-2. PubMed ID: 19761104 [No Abstract] [Full Text] [Related]
11. [Intravenous thrombolytic therapy in myocardial infarction (review)]. Staroverov II Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614 [No Abstract] [Full Text] [Related]
12. [Thrombolytic treatment of acute myocardial infarct. 1]. Soares-Costa JT; Soares-Costa TJ; Gabriel HM Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V. Ferreira D Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168 [No Abstract] [Full Text] [Related]
14. Pharmacologic reperfusion strategies for the treatment of ST-segment elevation myocardial infarction. Young JJ; Kereiakes DJ Rev Cardiovasc Med; 2003; 4(4):216-27. PubMed ID: 14668689 [TBL] [Abstract][Full Text] [Related]
15. Comparisons and controversies in clot buster drugs. Majoros KA Crit Care Nurs Q; 1993 Aug; 16(2):46-69. PubMed ID: 8353800 [No Abstract] [Full Text] [Related]
16. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Hilleman DE; Tsikouris JP; Seals AA; Marmur JD Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464 [TBL] [Abstract][Full Text] [Related]
17. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction]. Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494 [TBL] [Abstract][Full Text] [Related]
18. Chronic antithrombotic therapy in post-myocardial infarction patients. Sodhi S; Lee R; Ezekowitz M Clin Geriatr Med; 2006 Feb; 22(1):167-82, x. PubMed ID: 16377473 [TBL] [Abstract][Full Text] [Related]